top of page
The International
Radiosurgery Oncology Consortium for Kidney
(IROCK) Registry
The International Radiosurgery Oncology Consortium for Kidney (IROCK) collaborates on research into stereotactic ablative radiotherapy (SABR) for primary renal cell carcinoma (RCC). The primary purpose of the IROCK Registry is to evaluate the time between SABR treatment and recurrence (when cancer returns after treatment) that occurs in the area of the initial tumour, in patients with RCC. The secondary objective of the study will assess efficacy and survival outcomes.
More information
More about SABR in RCC
The IROCK Registry
IROCK's
work to date
No events at the moment
CONTACT US
The IROCK Registry database is housed and maintained by the Peter MacCallum Cancer Centre in Melbourne, Australia. Feel free to get in touch with the Registry Coordinator with questions or comments regarding the work of the registry.
bottom of page